Skip to content
Clinical ResearchResearch compound

Yohimbine

Plant-derived fat-burning supplement popular with athletes; can cause anxiety, a racing heart and raised blood pressure.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Yohimbine vial

DETAILED OVERVIEW

What is Yohimbine?

Yohimbine is a plant compound extracted from the bark of the West African Yohimbe tree, known among athletes as a fat-burning dietary supplement. In the United States it can be bought without a prescription as a dietary supplement, while in Hungary and Poland it is prescription-only. It was also used for erectile problems, but its effectiveness is disputed. It is not on the anti-doping list.

It blocks the receptors that put the brakes on fat breakdown, so in theory it speeds up the breakdown of stubborn fat on the belly and thighs; only a few small studies have been done in humans so far. It most often causes anxiety and panic attacks, but also a racing heart and a rise in blood pressure. Together with some antidepressants it can raise blood pressure to dangerous levels, and in people taking a drug called clonidine, a brain hemorrhage after a single use has been described. It is contraindicated in severe heart disease and anxiety disorders, and must not be used in pregnancy. The amount of active ingredient in commercial products often differs greatly from the label.

Mechanism

α2-adrenoceptor antagonist

Half-life

0.6-2 hours (short)

Onset

30-45 min

Legal status

USA: OTC supplement. EU: mixed (HU: prescription). WADA: not listed.

Data console

Lab data

Androgenic:Anabolic-
AR bindingN/A
Active half-life0.6-2 h
Detection windowN/A
AromatizationNot applicable – indole alkaloid α2-antagonist, NOT a steroid; no CYP19 interaction
HepatotoxicityLow – anxiogenic and cardiovascular risk dominates (tachycardia, hypertension); rare hepatotoxicity only at overdose (NIH LiverTox 2024)

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Anxiety, nervousness, panic attacks and inner tremor – the most common, dose-dependent effect from increased noradrenaline release via central α2 blockade.
  • Raised blood pressure and risk of hypertensive crisis, especially combined with MAOIs or tyramine-rich foods.
  • Tachycardia, palpitations and arrhythmias; rarely angina or myocardial infarction in overdose.
  • Insomnia and restlessness, especially with afternoon/evening dosing – CNS stimulation outlasts the short half-life.
  • Nausea, abdominal discomfort and vomiting, more common at high doses (>0.4 mg/kg).
  • Headache, dizziness, sweating and flushing from sympathomimetic activation.
  • Increased urinary frequency and urine output (inhibition of antidiuretic signalling).
  • Product-quality risk: many commercial yohimbine supplements are mislabelled with 0–12 mg/serving variance (Cohen 2015), causing unpredictable overdose.

Contraindications · 7

  • Chronic clonidine (or other α2-agonist) use: direct pharmacological conflict, documented intracranial haemorrhage after a single dose (Pham 2022) – absolute contraindication.
  • Concurrent MAOI, SSRI or tricyclic antidepressant use – risk of hypertensive crisis and serotonergic/adrenergic overload.
  • Serious cardiovascular disease: uncontrolled hypertension, coronary artery disease, arrhythmia or prior myocardial infarction.
  • Anxiety disorder, panic disorder or PTSD – α2 antagonism provokes panic attacks and anxiety.
  • Pregnancy and breastfeeding – oxytocin-like uterotonic effect and teratogenic uncertainty.
  • Severe kidney or liver disease – reduced CYP2D6 clearance leads to accumulation and increased toxicity.
  • Benign prostatic hyperplasia (BPH) – may worsen urinary symptoms.

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Yohimbine?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.